A Comparison of Exparel to Bupivacaine in TAP Block for Abdominal Gynecologic Surgery

Status unconfirmed · Phase 3

Conditions studied: Gynecologic Cancer, Post Operative Pain

In brief

This study evaluates the comparison between liposomal bupivacaine versus bupivacaine HCl in Transversus Abdominis Plane blocks for gynecologic surgery on the length of stay in the hospital, total narcotic use, and overall complications rates.

Key facts

Study ID

NCT03304444

Run by

Abington Memorial Hospital

People needed

128

Starts

2016-08-01

Expected to finish

2017-10-01

Last updated by the study team

2017-10-09

Who can join

Age: 18 and older, up to 99. Sex: female. Healthy volunteers: accepted.

You may qualify if…

• all patients undergoing planned exploratory laparotomy
• TAP blocks placed after the laparotomy incision is closed, but before the patient is awake, and placed under ultrasound guidance with correct identification of the correct abdominal plane.
• Consent for TAP block signed by patients preoperatively by anesthesiology

You may not qualify if…

• All pregnant patients
• All patients under 18 years of age
• minimally invasive surgery such as laparoscopy or robotic assisted laparoscopy
• medical contraindications to use of bupivacaine or liposomal bupivacaine such as severe hepatic and/or renal disease

Where it is running

• Abington Hospital Jefferson Health — Abington, Pennsylvania, United States (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.